Deferred Royalty Obligation Related to the Sale of Future Royalties - Financial Information (Details) - USD ($) $ in Thousands	12 Months Ended
Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Non-cash interest expense related to the sale of future royalties	$ (8,296)	$ (7,088)	$ (3,924)
Healthcare royalty partners IV, L.P \| Licensing revenue
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Amortization, effective interest rate, percent	25.40%	31.00%	34.70%

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 808
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479402/808-10-50-1

Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration